CEFPODOXIME VIATRIS 100 mg, film-coated tablet 10 tablets, CIP 3400939932149
Active ingredients: Cefpodoxime, Cefpodoxime proxetil
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet10 tablets, CIP 3400939932149orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFPODOXIME VIATRIS 100 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium de 10 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Apr 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68951100CIP73993214CIP133400939932149Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CEFPODOXIMEcomprimé | 100 mg · un comprimé | FT |
| CEFPODOXIME PROXÉTILcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.